Danaher names Julie Sawyer Montgomery CEO. Danaher stock gains 1.45 percent.
Published on 10/07/2026 at 15:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Danaher stock was trading at EUR 194.20 at Lang & Schwarz on October 7, 2026 at 3:35 p.m. CEST, up 1.45 percent from the prior close of EUR 191.43. Danaher said on October 1, 2026 that Julie Sawyer Montgomery had assumed the roles of president and CEO and joined the board.
New CEO starts before results
Montgomery's appointment puts a new executive at the helm ahead of Danaher's third-quarter report. Rainer Blair will serve as a senior advisor through March 31, 2027, giving the company a defined transition period.
Danaher scheduled its third-quarter 2026 earnings conference call for October 21, 2026 at 8:00 a.m. ET. That date gives investors the next formal checkpoint for the new leadership team.
Second-quarter growth was mixed
In the second quarter of 2026, Danaher generated USD 6.27 billion of revenue, while adjusted diluted earnings per share reached USD 1.94. Yahoo Finance reported that core revenue increased 3.00 percent year over year, and core growth excluding respiratory testing reached 4.50 percent.
The same second-quarter call showed a 27.10 percent adjusted operating margin and USD 1.30 billion of free cash flow. Management raised full-year 2026 adjusted diluted earnings-per-share guidance to USD 8.45-8.60 from USD 8.35-8.55, a higher range that contrasts with shipment timing pressure in bioprocessing.
RBC lifts target to USD 250
Markets Insider reported on October 5, 2026 that RBC Capital raised its Danaher price target from USD 215.00 to USD 250.00 and maintained an Outperform rating. The USD 250.00 target lies 16.17 percent above the USD 215.85 primary-exchange price quoted on October 7, 2026.
RBC attributed the change to peer valuation expansion rather than a company-specific development. That distinction matters because Danaher's operating update includes both improving life sciences demand and delayed bioprocessing shipments.
Stock trades below yearly high
On the NYSE, Danaher was last at USD 215.85 on October 7, 2026 at 9:42 a.m. ET. The 52-week range was USD 160.93 to USD 242.80, and the market capitalization was USD 151.7 billion on the same date.
The further course of trading is shown by the continuously updated real-time quote of Danaher stock.
Danaher stock facts
- Company: Danaher Corporation
- ISIN: US2358511028
- Ticker: DHR
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 7, 2026, 3:35 p.m. CEST): EUR 194.20
- Change versus prior close: plus 1.45 percent
- Prior close Lang & Schwarz (October 6, 2026): EUR 191.43
- Market capitalization: USD 151.7 billion (as of October 7, 2026)
- 52-week range: USD 160.93-242.80 (as of October 7, 2026)
- Sector / Industry: Healthcare / Life Sciences Tools and Services
- Next earnings date: October 21, 2026
